MedTrace Logo

Ureteral Reimplantation for the Treatment of Extrinsic Malignant Ureteral Obstruction

NCT02160652 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2017-10-17

No results posted yet for this study

Summary

A single center single arm prospective study, assessing the outcome of ureteral re-implantation for malignant ureteral obstruction.

Conditions

  • Ureteral Obstruction

Interventions

PROCEDURE

Laparoscopic ureteral re-implantation.

Laparoscopic ureteral re-implantation for the treatment of malignant ureteral obstruction.

Sponsors & Collaborators

  • Rabin Medical Center

    lead OTHER

Principal Investigators

  • David Margel, MD, PhD · Rabin Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-06-30
Primary Completion
2018-06-30
Completion
2018-06-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02160652 on ClinicalTrials.gov